Literature DB >> 33664964

The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

L Nicolas Gonzalez Castro1,2,3, Pieter Wesseling4,5.   

Abstract

Over the past 4 years, advances in molecular pathology have enhanced our understanding of CNS tumors, providing new elements to refine their classification and improve the 2016 World Health Organization (WHO) Classification of CNS tumors. The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy-Not Official WHO (cIMPACT-NOW) was formed in late 2016 by a group of neuropathology and neuro-oncology experts to provide practical recommendations (published as cIMPACT-NOW updates) to improve the diagnosis and classification of CNS tumors, in advance of the publication of a new WHO Classification of CNS tumors. Here we review the content of all the available cIMPACT-NOW updates and discuss the implications of each update for the diagnosis and management of patients with CNS tumors.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IDH-mutant gliomas; brain tumor classification; cIMPACT-NOW; glioblastoma; molecular pathology

Year:  2020        PMID: 33664964      PMCID: PMC7906262          DOI: 10.1093/nop/npaa055

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  21 in total

1.  Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.

Authors:  Drew Pratt; Siva Kumar Natarajan; Adam Banda; Caterina Giannini; Pankaj Vats; Carl Koschmann; Rajen Mody; Arul Chinnaiyan; Sriram Venneti
Journal:  Acta Neuropathol       Date:  2018-01-04       Impact factor: 17.088

2.  Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.

Authors:  David N Louis; Ken Aldape; Daniel J Brat; David Capper; David W Ellison; Cynthia Hawkins; Werner Paulus; Arie Perry; Guido Reifenberger; Dominique Figarella-Branger; Pieter Wesseling; Tracy T Batchelor; J Gregory Cairncross; Stefan M Pfister; Stefan Rutkowski; Michael Weller; Wolfgang Wick; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2017-01       Impact factor: 17.088

3.  cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).

Authors:  David N Louis; Pieter Wesseling; Werner Paulus; Caterina Giannini; Tracy T Batchelor; J Gregory Cairncross; David Capper; Dominique Figarella-Branger; M Beatriz Lopes; Wolfgang Wick; Martin van den Bent
Journal:  Acta Neuropathol       Date:  2018-01-25       Impact factor: 17.088

4.  Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.

Authors:  C Mircea S Tesileanu; Linda Dirven; Maarten M J Wijnenga; Johan A F Koekkoek; Arnaud J P E Vincent; Hendrikus J Dubbink; Peggy N Atmodimedjo; Johan M Kros; Sjoerd G van Duinen; Marion Smits; Martin J B Taphoorn; Pim J French; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

5.  Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

Authors:  Mitsuaki Shirahata; Takahiro Ono; Damian Stichel; Daniel Schrimpf; David E Reuss; Felix Sahm; Christian Koelsche; Annika Wefers; Annekathrin Reinhardt; Kristin Huang; Philipp Sievers; Hiroaki Shimizu; Hiroshi Nanjo; Yusuke Kobayashi; Yohei Miyake; Tomonari Suzuki; Jun-Ichi Adachi; Kazuhiko Mishima; Atsushi Sasaki; Ryo Nishikawa; Melanie Bewerunge-Hudler; Marina Ryzhova; Oksana Absalyamova; Andrey Golanov; Peter Sinn; Michael Platten; Christine Jungk; Frank Winkler; Antje Wick; Daniel Hänggi; Andreas Unterberg; Stefan M Pfister; David T W Jones; Martin van den Bent; Monika Hegi; Pim French; Brigitta G Baumert; Roger Stupp; Thierry Gorlia; Michael Weller; David Capper; Andrey Korshunov; Christel Herold-Mende; Wolfgang Wick; David N Louis; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-04-23       Impact factor: 17.088

6.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

7.  FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.

Authors:  Catherine T-S Chung; Gilda Da Cunha Santos; David M Hwang; Olga Ludkovski; Melania Pintilie; Jeremy A Squire; Ming-Sound Tsao
Journal:  J Clin Pathol       Date:  2010-07       Impact factor: 3.411

8.  DNA methylation-based classification of central nervous system tumours.

Authors:  David Capper; David T W Jones; Martin Sill; Volker Hovestadt; Daniel Schrimpf; Dominik Sturm; Christian Koelsche; Felix Sahm; Lukas Chavez; David E Reuss; Annekathrin Kratz; Annika K Wefers; Kristin Huang; Kristian W Pajtler; Leonille Schweizer; Damian Stichel; Adriana Olar; Nils W Engel; Kerstin Lindenberg; Patrick N Harter; Anne K Braczynski; Karl H Plate; Hildegard Dohmen; Boyan K Garvalov; Roland Coras; Annett Hölsken; Ekkehard Hewer; Melanie Bewerunge-Hudler; Matthias Schick; Roger Fischer; Rudi Beschorner; Jens Schittenhelm; Ori Staszewski; Khalida Wani; Pascale Varlet; Melanie Pages; Petra Temming; Dietmar Lohmann; Florian Selt; Hendrik Witt; Till Milde; Olaf Witt; Eleonora Aronica; Felice Giangaspero; Elisabeth Rushing; Wolfram Scheurlen; Christoph Geisenberger; Fausto J Rodriguez; Albert Becker; Matthias Preusser; Christine Haberler; Rolf Bjerkvig; Jane Cryan; Michael Farrell; Martina Deckert; Jürgen Hench; Stephan Frank; Jonathan Serrano; Kasthuri Kannan; Aristotelis Tsirigos; Wolfgang Brück; Silvia Hofer; Stefanie Brehmer; Marcel Seiz-Rosenhagen; Daniel Hänggi; Volkmar Hans; Stephanie Rozsnoki; Jordan R Hansford; Patricia Kohlhof; Bjarne W Kristensen; Matt Lechner; Beatriz Lopes; Christian Mawrin; Ralf Ketter; Andreas Kulozik; Ziad Khatib; Frank Heppner; Arend Koch; Anne Jouvet; Catherine Keohane; Helmut Mühleisen; Wolf Mueller; Ute Pohl; Marco Prinz; Axel Benner; Marc Zapatka; Nicholas G Gottardo; Pablo Hernáiz Driever; Christof M Kramm; Hermann L Müller; Stefan Rutkowski; Katja von Hoff; Michael C Frühwald; Astrid Gnekow; Gudrun Fleischhack; Stephan Tippelt; Gabriele Calaminus; Camelia-Maria Monoranu; Arie Perry; Chris Jones; Thomas S Jacques; Bernhard Radlwimmer; Marco Gessi; Torsten Pietsch; Johannes Schramm; Gabriele Schackert; Manfred Westphal; Guido Reifenberger; Pieter Wesseling; Michael Weller; Vincent Peter Collins; Ingmar Blümcke; Martin Bendszus; Jürgen Debus; Annie Huang; Nada Jabado; Paul A Northcott; Werner Paulus; Amar Gajjar; Giles W Robinson; Michael D Taylor; Zane Jaunmuktane; Marina Ryzhova; Michael Platten; Andreas Unterberg; Wolfgang Wick; Matthias A Karajannis; Michel Mittelbronn; Till Acker; Christian Hartmann; Kenneth Aldape; Ulrich Schüller; Rolf Buslei; Peter Lichter; Marcel Kool; Christel Herold-Mende; David W Ellison; Martin Hasselblatt; Matija Snuderl; Sebastian Brandner; Andrey Korshunov; Andreas von Deimling; Stefan M Pfister
Journal:  Nature       Date:  2018-03-14       Impact factor: 49.962

9.  Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.

Authors:  David Capper; Damian Stichel; Felix Sahm; David T W Jones; Daniel Schrimpf; Martin Sill; Simone Schmid; Volker Hovestadt; David E Reuss; Christian Koelsche; Annekathrin Reinhardt; Annika K Wefers; Kristin Huang; Philipp Sievers; Azadeh Ebrahimi; Anne Schöler; Daniel Teichmann; Arend Koch; Daniel Hänggi; Andreas Unterberg; Michael Platten; Wolfgang Wick; Olaf Witt; Till Milde; Andrey Korshunov; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-07-02       Impact factor: 17.088

Review 10.  Molecular pathology of tumors of the central nervous system.

Authors:  B W Kristensen; L P Priesterbach-Ackley; J K Petersen; P Wesseling
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

View more
  15 in total

1.  Glioblastoma with Gliomatosis Cerebri Growth Pattern Presenting as Rapidly Progressive Dementia.

Authors:  John Y Rhee; Luis Nicolas Gonzalez Castro
Journal:  Neurohospitalist       Date:  2022-02-11

2.  Bioethical implications of current state practices of molecular diagnostics in neuropathology.

Authors:  Wesley Wang; Dana Howard; Pierre Giglio; Diana Thomas; José Javier Otero
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

Review 3.  Emerging Biomarkers for Immunotherapy in Glioblastoma.

Authors:  Nadia Mensali; Else Marit Inderberg
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

Review 4.  Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas.

Authors:  Jayapalli Rajiv Bapuraj; Nicholas Wang; Ashok Srinivasan; Arvind Rao
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

5.  Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma.

Authors:  Dorothee Hölzl; Georg Hutarew; Barbara Zellinger; Hans U Schlicker; Christoph Schwartz; Peter A Winkler; Karl Sotlar; Theo F J Kraus
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-08       Impact factor: 4.553

6.  Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.

Authors:  Timothy E Richardson; Mariano S Viapiano; James F Lyon; Varshini Vasudevaraja; Kanish Mirchia; Jamie M Walker; Robert J Corona; Lawrence S Chin; Ivy Tran; Matija Snuderl
Journal:  Acta Neuropathol Commun       Date:  2021-06-30       Impact factor: 7.801

7.  Pathology-proven extradural ("distant") metastases of gliomas in adults in the Netherlands between 1971 and 2018: a systematic case series.

Authors:  Sanne J den Hartog; Anja van der Kolk; Annette Bruggink; Tatjana Seute; Pieter Wesseling; Joyce Wilbers
Journal:  Neurooncol Pract       Date:  2021-01-22

Review 8.  Role of RAGE and Its Ligands on Inflammatory Responses to Brain Tumors.

Authors:  Griffith Kyle Otazu; Mojtaba Dayyani; Behnam Badie
Journal:  Front Cell Neurosci       Date:  2021-12-16       Impact factor: 5.505

9.  Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.

Authors:  George S Stoyanov; Emran Lyutfi; Reneta Georgieva; Radoslav Georgiev; Deyan L Dzhenkov; Lilyana Petkova; Borislav D Ivanov; Ara Kaprelyan; Peter Ghenev
Journal:  Cureus       Date:  2022-02-01

Review 10.  Adolescent and young adult brain tumors: current topics and review.

Authors:  Fumiyuki Yamasaki
Journal:  Int J Clin Oncol       Date:  2022-01-22       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.